Significant results from new brain cancer drugs as Chroma platform matures
Posted: 4 September 2024 Innovative biotech company Noxopharm Limited (ASX:NOX) is pleased to announce substantial progress on its Chroma™ technology platform, with encouraging brain cancer results plus early work on leukaemia. Glioblastoma is the most frequent and lethal…
Blood test can help predict chronic lung disease in preterm babies
Posted: 3 September 2024 A blood test can help predict which preterm babies will go onto develop chronic lung disease, allowing for earlier diagnosis and more targeted treatments, according to a new study. The research, led by Murdoch…
Blood stem cell breakthrough could transform bone marrow transplants
Posted: 3 September 2024 Melbourne researchers have made a world first breakthrough into creating blood stem cells that closely resemble those in the human body. And the discovery could soon lead to personalised treatments for children with leukaemia…
MTPConnect Backs Start-ups In Heart Disease and Diabetes through New $28.5M TTRA Investment
Posted: 3 September 2024 MTPConnect will inject much-needed funding and support for Australian small to medium enterprises (SMEs) to commercialise innovative medical products to better treat cardiovascular disease and diabetes when it rolls out new investment through its…
New funds to Embrace rare genetic disorder research
Posted: 3 September 2024 Scientists at La Trobe University have received nearly $140,000 from rare disease charity Archie’s Embrace to investigate an under-researched genetic disorder which causes early-onset neurodegeneration in babies. The disorder, which causes a deficiency of…
Non-invasive testing a way of the future
Posted: 3 September 2024 A new collaborative study between the RMH and WEHI is the latest technology to test for early markers of kidney rejection via a simple urine test, hoping to bypass the need for invasive biopsies. Researchers at the RMH and WEHI are…
New clue into the curious case of our ageing immune system
Posted: 3 September 2024 A WEHI study could help solve a long-standing mystery into why a key immune organ in our bodies shrinks and loses its function as we get older. The thymus is an organ essential for…
Two-in-one breakthrough: Cutting-edge immunotherapy could hold promise for incurable brain cancer
Posted: 3 September 2024 Researchers at WEHI have identified a promising new two-in-one treatment that not only targets and destroys an aggressive form of brain cancer, but also helps the immune system develop a lasting defence against it. This…
Scientists discover how the body’s killer cells attack cancer
Posted: 3 September 2024 An international team of scientists are on the verge of a cancer breakthrough after working out how the body’s immune system targets cells devastated by the disease. A new study published in the journal Science…
2024 BioSymposium sponsors – Innovating antibody drug conjugates: From mechanisms to market
Web djsir.vic.gov.au/health-tech Email medtech.pharma@ecodev.vic.gov.au About us Victoria is home to world-class health technology companies and is a preferred location for many global leaders including CSL, Moderna, BioNTech, Illumina, Telix Pharmaceuticals and Pfizer. International companies partner with Victoria for its…
Nominations open for BioMelbourne Network’s Women in Leadership Awards 2025
Posted: 2 September 2024 BioMelbourne Network has opened nominations for its Women in Leadership Awards 2025. This prestigious event, now in its 11th year, continues to recognise and champion women who have made outstanding contributions in the healthtech…
Telix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
Posted: 28 August 2024 Telix today announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX101-CDx, (Pixclara®[1], 18F-floretyrosine or 18F-FET), an investigational PET[2] agent for the characterisation of progressive or…
